Glucocorticoid resistance syndrome caused by a novel NR3C1 point mutation.
In conclusion, in patients with clinically unexpected ACTH-dependent hypercortisolemia, primary glucocorticoid resistance (GRS) should be considered.
PMID: 30158362 [PubMed - as supplied by publisher]
Source: Endocrine Journal - Category: Endocrinology Tags: Endocr J Source Type: research
More News: Addison's Disease | Adrenal Insufficiency | Anxiety | Brain | Brain Cancers | Cancer | Cancer & Oncology | Cushing's Syndrome | Dexamethasone | Endocrinology | Genetics | Neurology | Oral Cancer | Orthopaedics | Osteoporosis | Ovarian Cancer | Ovaries | Weight Loss